This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
EasyJet (EZJ.L) would lift its pay-out ratio to 40% next year and had reached agreement with Airbus to add 27 planes to its fleet, in a sign of its continuing confidence. Closing price 1338.00p (Reuters)
Kier Group (KIE.L) Final dividend 49.5p up 6%, underlying profit before tax up 54% to £73.1m. The company are on course to meet board's expectations for current financial year. Closing price 1674.00p (Reuters)
Glaxosmithkline (GSK.L) - Britain's healthcare cost agency NICE has recommended a third new drug for melanoma, this time from GlaxoSmithKline , after the drug maker offered to supply it at a discount to the state-run National Health Service. Closing price 1434.00p. (Reuters)
Merlin (MERL.L) - Business has continued to trade well over the summer, bringing year to date like for like revenue growth to 6.7%. Profit growth in period has been consistent with management's expectations. Company confident that they can deliver another year of good underlying growth. Prospects for 2015 and beyond are attractive. Closing price 340.5p. (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Daily Mail | DMGT.L | -6.87% | -5.77% | -9.70% |
| Vodafone | VOD.L | -0.22% | 0.79% | -0.26% |
| BP | BP.L | -0.28% | 1.27% | -0.54% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research